| Issuer | % of Class | Filed |
|---|---|---|
|
Bio Green Med Solution, Inc.
13G/A
Amendment 4
BGMS · 23254L876
|
0% |
8/12/2026
Event 6/30/2026
|
|
Bio Green Med Solution, Inc.
13G/A
Amendment 3
BGMS · 23254L876
|
8.5% |
5/12/2026
Event 11/5/2025
|
|
Bio Green Med Solution, Inc.
13G/A
Amendment 2
BGMS · 23254L876
|
14.8% |
10/31/2025
Event 10/29/2025
|
|
Cyclacel Pharmaceuticals, Inc.
13G/A
Amendment 1
BGMS · 23254L876
|
20.8% |
9/2/2025
Event 9/1/2025
|
|
Cyclacel Pharmaceuticals, Inc.
13G
BGMS · 23254L876
|
9.8% |
8/18/2025
Event 7/28/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.